Meiji Yasuda Asset Management Co Ltd. Buys New Shares in CVS Health Corporation $CVS

Meiji Yasuda Asset Management Co Ltd. acquired a new position in CVS Health Corporation (NYSE:CVS) in the second quarter, Holdings Channel.com reports. The institutional investor acquired 30,493 shares of the pharmacy operator’s stock, valued at approximately $3,155,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CVS. Caitong International Asset Management Co. Ltd lifted its stake in CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 281 shares during the period. Swiss RE Ltd. acquired a new position in CVS Health in the fourth quarter valued at about $26,000. Kilter Group LLC bought a new stake in CVS Health during the second quarter worth about $27,000. Sankala Group LLC acquired a new stake in shares of CVS Health during the fourth quarter worth approximately $28,000. Finally, Global Trust Asset Management LLC raised its stake in shares of CVS Health by 344.8% in the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 300 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Wells Fargo & Company increased their price target on CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Deutsche Bank Aktiengesellschaft lifted their price objective on CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Piper Sandler reissued an “overweight” rating and issued a $113.00 price objective on shares of CVS Health in a research note on Monday, June 1st. Argus increased their target price on CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday, August 19th. Finally, Robert W. Baird set a $107.00 price target on CVS Health in a report on Thursday, August 6th. Twenty-two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Stock Performance

Shares of CVS Health stock opened at $94.06 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The firm has a 50 day simple moving average of $101.88 and a 200 day simple moving average of $89.08. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The firm has a market cap of $120.31 billion, a P/E ratio of 24.88, a P/E/G ratio of 0.85 and a beta of 0.61.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio is 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.